Loading...
XHKG
2138
Market cap99mUSD
Aug 08, Last price  
0.66HKD
1D
0.00%
1Q
3.13%
Jan 2017
-76.43%
IPO
-78.00%
Name

EC Healthcare

Chart & Performance

D1W1MN
P/E
—
P/S
0.19
EPS
—
Div Yield, %
—
Shrs. gr., 5y
3.74%
Rev. gr., 5y
17.85%
Revenues
4.21b
+8.66%
234,710,089489,897,158621,352,686707,920,067974,902,8931,322,141,4411,852,452,0591,948,500,6432,080,403,3942,919,500,0003,875,377,0004,211,033,999
Net income
-19m
L
-32,301,00381,121,682174,415,159148,663,969200,702,539279,223,799361,105,819286,576,155192,865,000197,501,00069,654,000-18,947,000
CFO
689m
+13.28%
11,549,478144,593,319158,558,02476,196,212179,980,510323,771,927238,450,798574,374,370616,451,889603,476,000608,321,000689,101,000
Dividend
Dec 28, 20230.005 HKD/sh

Profile

EC Healthcare, an investment holding company, engages in the provision of medical and healthcare services in Hong Kong, Macau, and the People's Republic of China. The company operates through three segments: Medical, Aesthetic Medical and Beauty and Wellness, and Others. It provides quasi-medical, beauty and wellness, medical imaging, medical surgery, aesthetic medical beauty, aesthetic medical, dental, hair treatment, vaccine, chiropractic, psychological, and orthopedics services. It also offers administrative, management, laboratory testing, performance marketing, marketing, and travel agency services; sells beauty and skincare products; operates in healthcare machines and property investment holding businesses; and provides multi-channel networking and related services, and veterinary services. The company offers products and services primarily under private-label brands, such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. The company was formerly known as Union Medical Healthcare Limited and changed its name to EC Healthcare in April 2021. EC Healthcare was founded in 2005 and is headquartered in Mong Kok, Hong Kong.
URL
https://echealthcare.com/
IPO date
Mar 11, 2016
Employees
2,579
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
4,211,034
8.66%
3,875,377
32.74%
Cost of revenue
3,932,666
3,605,797
Unusual Expense (Income)
NOPBT
278,368
269,580
NOPBT Margin
6.61%
6.96%
Operating Taxes
1,179
29,162
Tax Rate
0.42%
10.82%
NOPAT
277,189
240,418
Net income
(18,947)
-127.20%
69,654
-64.73%
Dividends
(55,689)
(118,004)
Dividend yield
Proceeds from repurchase of equity
(358,846)
BB yield
Debt
Debt current
392,373
400,387
Long-term debt
1,894,350
1,131,881
Deferred revenue
514,089
Other long-term liabilities
234,037
231,677
Net debt
970,294
161,594
Cash flow
Cash from operating activities
689,101
608,321
CAPEX
(161,223)
(412,492)
Cash from investing activities
(358,355)
(715,622)
Cash from financing activities
(486,464)
(51,312)
FCF
475,821
(152,921)
Balance
Cash
606,315
726,840
Long term investments
710,114
643,834
Excess cash
1,105,877
1,176,905
Stockholders' equity
385,069
353,243
Invested Capital
3,855,435
3,721,895
ROIC
7.32%
6.87%
ROCE
6.42%
6.45%
EV
Common stock shares outstanding
1,185,211
1,184,284
Price
Market cap
EV
EBITDA
903,913
856,315
EV/EBITDA
Interest
100,837
71,669
Interest/NOPBT
36.22%
26.59%